Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Actinic Keratosis Market Size, Value And Growth Trajectory Through 2030
The actinic keratosis market has demonstrated significant growth in recent years. It is anticipated to expand from $8.42 billion in 2025 to $8.91 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.8%. The historic period’s expansion is attributable to factors such as increasing UV exposure and sunburn incidence, the limited availability of effective topical agents, a rising prevalence of skin cancer, the development of dermatology infrastructure, and the adoption of conventional surgical procedures.
The actinic keratosis market is projected to experience substantial expansion in the coming years, reaching $11.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period is driven by factors such as the advancement of photodynamic therapies, a rise in the application of combined topical and procedural treatments, the broadening of hospital and dermatology clinic infrastructures, heightened consumer understanding of the benefits of early intervention, and the emergence of novel homecare treatment options. Key trends anticipated over this period encompass a greater emphasis on sun protection and overall skin health, an uptick in the utilization of non-invasive photodynamic therapy, increased adoption of topical therapeutics for early-stage actinic keratosis, the proliferation of dermatology clinics and homecare treatments, and a growing inclination towards combination therapy approaches.
Get A Free Sample Report With In-Depth Market Insights:
Actinic Keratosis Market Growth Catalysts And Demand Drivers
A rise in severe sunburn incidents is anticipated to drive the expansion of the actinic keratosis market in the future. Intense skin burns, known as severe sunburns, stem from excessive ultraviolet (UV) radiation exposure, manifesting as redness, pain, swelling, and occasionally blisters. Factors contributing to sunburns include extended exposure to ultraviolet (UV) radiation, insufficient sun protection, more outdoor pursuits during intense UV periods, and escalating temperatures from climate change. Sunburns induce actinic keratosis by virtue of ultraviolet (UV) radiation harming the DNA within skin cells, causing mutations that interfere with regular cell processes and fostering the formation of precancerous lesions, particularly after recurrent or extended sun exposure. As an illustration, in May 2024, Melanoma Focus, a UK-based charity, reported 201 hospital admissions for sunburn in 2022-23, encompassing 89 children and 25 babies under one year old. The same charity also discovered that 66% of UK adults aged 16-65 recalled having sunburns in childhood, with 65% of these individuals experiencing severe sunburns accompanied by blisters at least once. This figure escalated to 77% for individuals possessing light, pale, or white skin tones. Consequently, the escalating incidence of severe sunburns is propelling the expansion of the actinic keratosis market.
Actinic Keratosis Market Segment Performance And Emerging Opportunities
The actinic keratosis market covered in this report is segmented –
1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types
2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies
3) By End-User: Hospitals, Dermatology Clinics, Homecare Settings, Other End-Users
Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac
2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication
3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy
4) By Other Treatment Types: Laser Therapy, Combination Therapies
Actinic Keratosis Market Trends Shaping Long-Term Demand
Major companies operating within the actinic keratosis market are directing their focus toward developing topical ointments designed to effectively target and eliminate precancerous lesions. These efforts aim to decrease recurrence rates and enhance patient compliance through shorter treatment durations and improved safety profiles. Topical ointments represent medicated creams or gels applied directly to the affected skin, featuring active ingredients like tirbanibulin, which function by targeting abnormal keratinocytes to treat precancerous lesions. For instance, in June 2024, Almirall SA, a Spain-based biopharmaceutical company, obtained approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) to broaden the use area for its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment operates as a microtubule inhibitor, engineered to prevent the proliferation of abnormal keratinocytes, thereby effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.
Actinic Keratosis Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the actinic keratosis market are Galderma SA, LEO Pharma A/S, Almirall S.A., Bausch Health Companies Inc., Perrigo Company plc, Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GSK plc, Amgen Inc., Incyte Corporation, Aclaris Therapeutics Inc., Biofrontera AG, Hill Dermaceuticals Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc.
View The Full Actinic Keratosis Market Report:
Actinic Keratosis Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the actinic keratosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.